Nicolas Cuburu, Ph.D.

Nicolas Çuburu, Ph.D.

  • Center for Cancer Research
  • National Cancer Institute


​Dr. Nicolas Çuburu’s research interests include vaccines, cancer immunotherapy, T cell memory, and human papillomavirus. His studies focus on the development of vaccines against sexually transmitted infections and immunotherapeutic agents against intraepithelial neoplasia based on viral vectors and antiviral immunity.  Dr. Cuburu has a Ph.D. in Immunology and Microbiology from the University of Nice-Cote d'Azur (Nice, France).

Areas of Expertise

Human Papillomavirus
T Cell Memory
Cancer Immunotherapy
Viral Vectors
Intraepithelial Neoplasia


Selected Publications

A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8+ Memory T Cells.

Çuburu N, Kim R, Guittard GC, Thompson CD, Day PM, Hamm DE, Pang YS, Graham BS, Lowy DR, Schiller JT
The Journal of Immunology. 202: 1250-1264, 2019. [ Journal Article ]

Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8(+) T cell responses against HPV16 oncoproteins.

Çuburu N, Khan S, Thompson CD, Kim R, Vellinga J, Zahn R, Lowy DR, Scheper G, Schiller JT
International Journal of Cancer. 142: 1467-1479, 2018. [ Journal Article ]

Moving forward with human papillomavirus immunotherapies.

Çuburu N, Schiller JT
Human Vaccines and Immunotherapeutics. 12: 2875-2880, 2016. [ Journal Article ]

Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.

Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT
Journal of Clinical Investigation. 122: 4606-4620, 2012. [ Journal Article ]